Skip to main navigation
Prelude Therapeutics
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • JAK2V617F
    • KAT6A
    • Precision DACs
    • Discovery Engine
    • Publications
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact

Governance Documents

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • JAK2V617F
    • KAT6A
    • Precision DACs
    • Discovery Engine
    • Publications
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact

Governance Documents

Code of Business Conduct and Ethics
Corporate Governance Guidelines

Committee Charters

Audit Committee
Compensation Committee
Nominating and Corporate Governance Committee
Print Page
RSS Feeds
Email Alerts
Search
preludetx.com

© Prelude Therapeutics
175 Innovation Blvd
Wilmington, DE 19805
(302) 467-1280

  • About
  • Science
  • Investors
  • News
  • Life at Prelude
  • Contact
visit our Twitter page visit our LinkedIn page Terms of Use Privacy Policy
logo
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • JAK2V617F
    • KAT6A
    • Precision DACs
    • Discovery Engine
    • Publications
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact